ATRO Medical B.V., based in the Netherlands, has been recognized by Johnson & Johnson Innovation as an Awardee in the Veterans Lead QuickFire Challenge. The Dutch startup company, founded in 2017, has invented a novel prosthetic meniscus—named “Trammpolin®”—to relieve pain and restore knee mobility in patients suffering from knee osteoarthritis (OA).
The Quickfire Challenge series is a collaboration between Johnson & Johnson Innovation and Johnson & Johnson’s Office of Military and Veterans Affairs. Innovators from several fields are invited to submit ideas which address military community health care needs—which encompass cardiovascular disease, kidney disease, oncology, orthopedic and musculoskeletal disease, physical trauma management, respiratory health, and vision loss.
The incidence of knee OA is reportedly 10 times higher in military personnel and therefore a very promising disease category for this J&J award program.